Business
Annual Report and Accounts
Annual Report and Accounts.
About this update from Immupharma Plc
[{"type":"text","content":"\n RNS Number : 3926N Immupharma PLC 10 June 2010 \n \n\n\n\n\n\nFor Immediate Release\n\n\n10 June 2010\n\n\n\n\n \n \n \nImmuPharma PLC\n \nAnnual Report and Accounts\nNotice of Annual General Meeting : 17 June 2010\n \n \nIn accordance with Rule 20 of the AIM Rules, ImmuPharma PLC (AIM:IMM), the specialist drug discovery and development company, confirms that the Annual Report and Accounts for the year ended 31 December 2009, has been posted to shareholders. \n \nThe annual report is available, in electronic form, for download on the Company's website www.immupharma.com. \n \nThe Company's Annual General Meeting will be held on 17 June 2010 at 11am at 50 Broadway, London, SW1H 0BL.\n \n- Ends -\n \n \n \nFor further information please contact: \n \n\n\n\n\nImmuPharma PLC: \n\n\n\n\n\n\n\nDimitri Dimitriou, Chief Executive Officer\n\n\n+44 20 7152 4080\n\n\n\n\nRichard Warr, Chairman\n\n\n+44 20 7152 4080\n\n\n\n\n\n\n\n\n\n\n\n\nBuchanan Communications\n\n\n+ 44 20 7466 5000\n\n\n\n\nLisa Baderoon\n\n\nwww.buchanan.uk.com\n\n\n\n\nCatherine Breen\n\n\n\n\n\n\n\nGeorge Prassas\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nPanmure Gordon & Co\n\n\n\n\n\n\n\nAndrew Burnett\n\n\n+44 151 243 0963\n\n\n\n\nRakesh Sharma\n\n\n\n\n\n\n\n \n\nThis information is provided by RNSThe company news service from the London Stock Exchange END ACSFMMLTMBABMIM \n ","length":5894,"tagName":"div"}]